Ipsen Stock price

Equities

IPN

FR0010259150

Pharmaceuticals

Real-time Euronext Paris 09:44:24 2024-03-05 am EST 5-day change 1st Jan Change
100.7 EUR -1.85% Intraday chart for Ipsen -2.71% -6.67%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 3.44B 3.73B Sales 2025 * 3.67B 3.98B Capitalization 8.47B 9.19B
Net income 2024 * 663M 719M Net income 2025 * 736M 798M EV / Sales 2024 * 2.3 x
Net cash position 2024 * 571M 620M Net cash position 2025 * 1.19B 1.3B EV / Sales 2025 * 1.98 x
P/E ratio 2024 *
12.8 x
P/E ratio 2025 *
11.6 x
Employees 5,325
Yield 2024 *
1.15%
Yield 2025 *
1.18%
Free-Float 41.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.07%
1 week-1.93%
Current month-0.29%
1 month-3.97%
3 months-0.39%
6 months-11.51%
Current year-5.93%
More quotes
1 week
99.70
Extreme 99.7
103.80
1 month
99.70
Extreme 99.7
109.70
Current year
99.70
Extreme 99.7
110.60
1 year
99.70
Extreme 99.7
130.70
3 years
65.90
Extreme 65.9
130.70
5 years
34.20
Extreme 34.2
130.70
10 years
28.24
Extreme 28.235
155.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 20-06-30
Director of Finance/CFO 54 14-11-02
Chairman 66 10-11-21
Members of the board TitleAgeSince
Director/Board Member 61 22-01-20
Director/Board Member 65 15-05-26
Chairman 66 10-11-21
More insiders
Date Price Change Volume
24-03-05 100.7 -1.85% 10 272
24-03-04 102.6 +1.08% 43,442
24-03-01 101.5 -0.29% 69,641
24-02-29 101.8 +0.20% 291,182
24-02-28 101.6 -1.84% 42,296

Real-time Euronext Paris, March 05, 2024 at 03:51 am EST

More quotes
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (78.6%); - neuroscience (20%); - rare diseases (1.4%). At the end of 2022, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide. Net sales (excluding divested operations) are distributed geographically as follows: Europe (40.9%), North America (34.1%) and other (25%). In July 2022, the group divested its family health products manufacturing business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
102.6 EUR
Average target price
124.8 EUR
Spread / Average Target
+21.66%
Consensus
  1. Stock
  2. Equities
  3. Stock Ipsen - Euronext Paris
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW